LUNG
Pulmonx Corporation
1.47
2 x 1.07
2 x 1.68
bid
ask
+
0.00
0.00%
2 @ 08:44 AM
1.49 +0.02 (1.36%)
| Ytd | -33.48% | |
| 1y | -45.35% |
day range
1.13
52 week range
3.88
| Open | Prev Close | 1.47 | Low | High | Mkt Cap | 62.09M | |||
| Vol | 0.00 | Avg Vol | 488.77K | EPS | -1.30 | P/E | N/A | Forward P/E | -3.91 |
| Beta | 0.68 | Short Ratio | 3.62 | Inst. Own | 94.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 1.38 | 200-d Avg | 1.64 | 1yr Est | 11.92 |
| Income Statement | |||
| Total Revenue | 20.59M | ||
| Revenues (USD) | 20.59M | ||
| Cost of Revenue | 4.54M | ||
| Gross Profit | 16.04M | ||
| Operating Expenses | 29.00M | ||
| Research and Development Expense | 4.90M | ||
| Selling, General and Administrative Expense | 24.10M | ||
| Operating Income | -12.96M | ||
| Interest Expense | 976.00K | ||
| Income Tax Expense | 149.00K | ||
| Net Income | -13.65M | ||
| Net Income Common Stock | -13.65M | ||
| Net Income Common Stock (USD) | -13.65M | ||
| Consolidated Income | -13.65M | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -12.53M | ||
| Earning Before Interest & Taxes (USD) | -12.53M | ||
| Weighted Average Shares | 41.90M | ||
| Weighted Average Shares Diluted | 41.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 61.83M | ||
| Cash and Equivalents (USD) | 61.83M | ||
| Trade and Non-Trade Receivables | 10.83M | ||
| Current Assets | 92.75M | ||
| Property, Plant & Equipment Net | 19.71M | ||
| Total Assets | 119.97M | ||
| Debt Current | 1.34M | ||
| Total Debt | 56.29M | ||
| Current Liabilities | 18.91M | ||
| Debt Non-Current | 54.95M | ||
| Total Liabilities | 74.21M | ||
| Accumulated Retained Earnings (Deficit) | -535.21M | ||
| Accumulated Other Comprehensive Income | 2.17M | ||
| Shareholders Equity | 45.76M | ||
| Shareholders Equity (USD) | 45.76M | ||
| Assets Non-Current | 27.22M | ||
| Total Debt (USD) | 56.29M | ||
| Deferred Revenue | 32.00K | ||
| Goodwill and Intangible Assets | 2.33M | ||
| Inventory | 20.13M | ||
| Liabilities Non-Current | 55.30M | ||
| Trade and Non-Trade Payables | 3.47M | ||
| Tax Liabilities | 401.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 635.00K | ||
| Net Cash Flow from Financing | 2.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.18M | ||
| Capital Expenditure | -9.00K | ||
| Issuance (Purchase) of Equity Shares | 241.00K | ||
| Issuance (Repayment) of Debt Securities | 1.79M | ||
| Net Cash Flow from Investing | -9.00K | ||
| Net Cash Flow from Operations | -10.10M | ||
| Effect of Exchange Rate Changes on Cash | -100.00K | ||
| Share Based Compensation | 4.14M | ||